Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Consumer Goods Press Releases .
Press releases published on August 12, 2025
ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
– Data from ASPEN-06 trial highlights CD47 expression as a key predictive biomarker of greater response to evorpacept in HER2+ Gastric Cancer; updated data to be presented at a medical conference in Q4 2025 – Phase 2 ASPEN-Breast evorpacept trial design …
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
GlobeNewswire
·
August 12, 2025
Presented positive new clinical data demonstrating high rates of durable complete responses from the Phase 1/2 trial of LYL314 for the treatment of aggressive large B-cell lymphoma Initiated the PiNACLE pivotal trial of LYL314 in patients with large B-cell …
SELLAS Life Sciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 12, 2025
- Positive IDMC Recommendation to Continue Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in AML Without Modification; Final Analysis Anticipated by Year-end 2025 – - Reported Positive Phase 2 Results of SLS009 in Relapsed/Refractory (r/r) Acute …
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
• New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates • Lead siRNA candidates show potent knockdown of LAT1 and VAV1, targets potentially relevant to T cell- …
Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 12, 2025
Topline results for RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, expected in 4Q2025 Enrollment continues in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for prophylaxis of HAE attacks; topline …
SKYX Reports Increase of 15% with Record Second Quarter 2025 Revenues of $23.1 Million Compared to $20.1 Million for First Quarter 2025 as it Continues to Grow its Market Penetration in the U.S. and Canadian Markets
GlobeNewswire
·
August 12, 2025
Company reports $15.7 million in cash, cash equivalents, and restricted cash, as compared to $12.3 million as of March 31, 2025. SKYX Continues to Leverage its Cash Position Through its E-Commerce Platform of 60 Websites among Other Methods Including …
Mushroom by Hyunjae Noh Wins Bronze in A' Furniture Design Awards
EIN Presswire
·
August 12, 2025
Innovative side table crafted from repurposed wood scraps recognized for sustainable design and unique aesthetic COMO, CO, ITALY, August 12, 2025 /EINPresswire.com/ -- The A' Design Award, a highly respected and well-recognized award in the field of …
Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 12, 2025
Topline data for registrational Phase 2 trial of KYV-101 in stiff person syndrome (SPS) and BLA submission anticipated in 1H 2026 Registrational Phase 3 KYV-101 trial in myasthenia gravis (MG) to include ~60 patients with enrollment to initiate by year-end …
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
GlobeNewswire
·
August 12, 2025
MZE782 Phase 1 Trial in Healthy Volunteers to Provide Proof of Mechanism Data for Phenylketonuria (PKU) and Chronic Kidney Disease (CKD) Expected in Q3 2025 MZE829 Phase 2 HORIZON Trial Actively Enrolling Patients with APOL1-Mediated Kidney Disease; …
Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
August 12, 2025
First patient treated with FT819 off-the-shelf CAR T-cell product candidate following fludarabine-free conditioning for severe lupus nephritis demonstrated durability of response with drug-free definition of remission in systemic lupus erythematosus (DORIS …
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update
GlobeNewswire
·
August 12, 2025
PIVOT-PO Phase 3 trial evaluating tebipenem Hbr in complicated urinary tract infection (cUTI) patients stopped early for efficacy following review by independent data monitoring committee (IDMC) Spero, along with its development partner, GSK, plans to …
Pathway Health Recognized as a 2025 Minnesota Star Tribune National Standard Top Workplace for the Third Consecutive Year
GlobeNewswire
·
August 12, 2025
LAKE ELMO, Minn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Pathway Health, a leading provider of health care consulting services, interim and permanent leadership, technology implementation, and training solutions, has been recognized as a 2025 Minnesota Star …
WOOF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Petco Health and Wellness Company, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 12, 2025
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
TSLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tesla, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 12, 2025
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 12, 2025
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
DDD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that 3D Systems Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 12, 2025
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
IRBT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRobot Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
August 12, 2025
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock
GlobeNewswire
·
August 12, 2025
Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary endpoint: 90-day Mortality 17.4% lower with PMX and >99% …
Pest Control Expert Brittany Thacker Explains Fall Bug Surges in HelloNation Magazine
GlobeNewswire
·
August 12, 2025
JASPER, Ga., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Why do bugs seem to flood into homes during the fall months? According to Brittany Thacker of Daniel …
Landscape Expert Jess Aragon of Timberrock Landscape Center Explains What to Do Before You Start a DIY Yard Project in HelloNation Magazine
GlobeNewswire
·
August 12, 2025
WINDSOR, Colo., Aug. 12, 2025 (GLOBE NEWSWIRE) -- What should I do before starting a DIY yard project? Homeowners who ask this question often hope to improve their outdoor spaces with their own effort, but may not know where to begin. According to …